Sreedhar R Adapa, MD
Nephrology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · The Nephrology Group Inc · Altura Centers for Health
Looking this up.
Hospitals listed: 052628 · 053506 · 552594 · 552721 · 552806 · Adventist Health Hanford · Adventist Health Reedley · Adventist Health Tulare · Kaweah Health Medical Center · Sierra View Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Adapa’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A123534 · Current
Licensed to practise in California · since 2012 · expires 2028-07-31 · Andhra University, Rangaraya Medical College Aka University of Health Sciences Vijayawada.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health HanfordHanford, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.277, Oct 2024 – Sep 2025
- Adventist Health ReedleyReedley, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 76% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Adventist Health TulareTulare, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Kaweah Health Medical CenterVisalia, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Kaweah Delta Health Care DistrictPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 239.86 (194.11 to 285.6) · 104 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025
- Sierra View Medical CenterPorterville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPatients rate it 2 of 5 · 52% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Hanford
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.277 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 614 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.38 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.5 (130.11 to 250.89) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 269 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.2 · 145 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 1,486 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,684 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 3,819 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.67 (0.36 to 4.98) · 613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 154 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.65 (1.02 to 4.28) · 598 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.24 (0 to 16.19) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 147 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 1) · 3,186 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.418 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.574 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 38 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 14.5 · 302 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 22 · 380 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 407 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 113 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10 to 17) · 896 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 228 cases | No different | Jan 2024 – Dec 2024 |
What patients said (947 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Adventist Health Reedley
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 41 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 101 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.45) · 169 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0 to 1.93) · 142 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.929 | No different | Oct 2024 – Sep 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -28.8 · 37 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 39 cases | None | Jul 2023 – Jun 2025 |
What patients said (133 patients answered, 10% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Adventist Health Tulare
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 1 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.05 (0 to 2.13) · 41 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.48 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 29 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.9 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 49 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 441 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 835 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 870 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.83 (1.25 to 6.42) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.25 (0.54 to 3.95) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.44 (0 to 1.57) · 681 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.436 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 94 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.4 · 67 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.4 · 129 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 141 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 46 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 100 cases | No different | Jan 2024 – Dec 2024 |
What patients said (219 patients answered, 14% of those asked)
| Cleanliness | 5 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 1 |
| Discharge information | 5 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 52% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 65% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
See every measure and the patient survey for Kaweah Health Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 3 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 239.86 (194.11 to 285.6) · 104 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.22 (0.28 to 2.16) · 1,600 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.53 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.4 · 145 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 285 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.8 · 626 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.1 · 741 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 373 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,927 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,045 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.01 to 0.38) · 9,267 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.72 (1.81 to 5.63) · 2,251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.53 to 3.61) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.79 (0.45 to 3.13) · 2,231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.88 (1.1 to 12.66) · 799 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.59 (0 to 7.19) · 759 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 416 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 0.89) · 8,159 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 43 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.728 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.405 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.023 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.551 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 344 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 799 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17 · 286 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 31.4 · 686 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -6 · 734 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 776 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.6 to 7.6) · 202 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.9 (6.6 to 11.9) · 202 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 317 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.3 to 14) · 1,748 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 680 cases | No different | Jan 2024 – Dec 2024 |
What patients said (435 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sierra View Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 10 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 548 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.64 to 1.51) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 11.5 · 99 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 58 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.2 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 21.4 · 330 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.8 · 112 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.7 · 938 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.37 (0.15 to 0.6) · 2,512 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,538 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.04 (1.54 to 6.53) · 287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.53 to 3.93) · 280 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.81 (1.82 to 21.81) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.99 (2.68 to 11.29) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.05 (0.54 to 3.56) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,881 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 27 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.606 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 57 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 170 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.8 · 55 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -37.5 · 145 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 336 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 362 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.8 (3.8 to 8.7) · 84 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.9 to 14) · 84 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10 to 17.3) · 788 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 188 cases | No different | Jan 2024 – Dec 2024 |
What patients said (325 patients answered, 12% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 57% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 52% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$607,841
Medicare paid this office $607,841 for 762 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 64 | $122,775 | $278 |
| Return visit (30+ min) | 418 | $75,876 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 230 | $58,577 | $61 |
| Home dialysis services per month (20 years or older) | 33 | $57,189 | $229 |
| Parathormone (parathyroid hormone) level | 342 | $33,539 | $40 |
See all 42 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 64 | $122,775 | $278 |
| Return visit (30+ min) | 418 | $75,876 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 230 | $58,577 | $61 |
| Home dialysis services per month (20 years or older) | 33 | $57,189 | $229 |
| Parathormone (parathyroid hormone) level | 342 | $33,539 | $40 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 50 | $23,673 | None |
| Vitamin d-3 level | 336 | $23,066 | $29 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 50 | $22,530 | $230 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $18,555 | $133 |
| Dialysis services, 1 physician visit per month (20 years or older) | 14 | $14,437 | $162 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 416 | $12,730 | $13 |
| Folic acid level, serum | 343 | $11,948 | $14 |
| Ferritin (blood protein) level | 343 | $11,131 | $13 |
| Cyanocobalamin (vitamin b-12) level | 341 | $10,940 | $15 |
| Cystatin c (enzyme inhibitor) level | 283 | $10,874 | $18 |
| Blood test, comprehensive group of blood chemicals | 347 | $8,863 | $10 |
| Insertion of needle into vein for collection of blood sample | 359 | $8,720 | $9 |
| New patient visit (45+ min) | 63 | $8,017 | $127 |
| Iron binding capacity | 339 | $6,918 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 348 | $6,470 | $8 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 52 | $5,865 | $101 |
| Magnesium level | 347 | $5,619 | $7 |
| Iron level | 339 | $5,118 | $6 |
| Red blood count automated, with additional calculations | 348 | $4,598 | $5 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 19 | $4,573 | None |
| Phosphate level | 347 | $3,987 | $5 |
| Creatinine level to test for kidney function or muscle injury | 330 | $3,949 | $5 |
| Complete ultrasound study of arm and leg arteries | 17 | $3,543 | $104 |
| Uric acid level, blood | 329 | $3,497 | $4 |
| Injection of drug or substance under skin or into muscle | 53 | $3,168 | $12 |
| Total protein level, urine | 327 | $2,788 | $4 |
| Hemodialysis procedure with physician evaluation | 29 | $1,734 | $56 |
| Complete ultrasound scan behind abdominal cavity | 18 | $1,643 | $91 |
| Measurement of complement (immune system proteins), antigen, | 62 | $1,411 | $12 |
| Limited ultrasound scan behind abdominal cavity | 27 | $1,379 | $49 |
| Dialysis services, per day, less than full month service (20 years or older) | 12 | $1,114 | $8 |
| Hemoglobin a1c level | 42 | $447 | $10 |
| Blood test, lipids (cholesterol and triglycerides) | 30 | $407 | $13 |
| Blood test, thyroid stimulating hormone (tsh) | 17 | $281 | $16 |
| Red blood cell concentration measurement | 39 | $276 | $2 |
| Blood count, hemoglobin | 39 | $276 | $2 |
| Urine microalbumin (protein) level | 34 | $198 | $6 |
Who their Medicare patients are
762 Original Medicare patients in 2024. Average age 72 · Under 65 21% · 85 and older 14% · Women 53% · Also on Medicaid 61% · Health risk score 3.45. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 67% · Coronary heart disease 47% · Heart failure 43% · Depression 26% · COPD 24% · Atrial fibrillation 23% · Cancer 13% · Dementia 12% · Stroke 12%.
The office billed $2,297,774, Medicare allowed $743,599 and paid $607,841; for 24,816 services of 59 kinds; $28,250 of it was for drugs given in the office and $579,590 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 762 | 24,816 | 72 | 3.45 | $2,297,774 | $607,841 |
| 2023 | 625 | 16,276 | 71 | 3.82 | $1,738,674 | $474,607 |
| 2022 | 734 | 17,645 | 72 | 3.58 | $1,812,492 | $491,828 |
| 2021 | 724 | 14,255 | 70 | 3.75 | $1,667,313 | $495,907 |
| 2020 | 755 | 12,307 | 71 | 4.15 | $1,104,908 | $428,318 |
| 2019 | 766 | 13,497 | 70 | 4.81 | $943,629 | $468,459 |
| 2018 | 746 | 9,541 | 68 | 5.20 | $796,461 | $438,051 |
| 2017 | 737 | 9,063 | 68 | 5.21 | $794,424 | $484,911 |
| 2016 | 566 | 3,217 | 68 | 5.27 | $477,385 | $281,966 |
| 2015 | 841 | 2,644 | 70 | 4.70 | $614,702 | $276,155 |
| 2014 | 646 | 2,742 | 72 | 3.20 | $666,487 | $199,267 |
| 2013 | 160 | 522 | 71 | 3.51 | $115,290 | $35,173 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 37 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 60 | $120,549 | $278 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 210 | $51,165 | $62 |
| Return visit (30+ min) | 256 | $40,949 | $100 |
| Home dialysis services per month (20 years or older) | 27 | $38,640 | $231 |
| Parathormone (parathyroid hormone) level | 246 | $23,794 | $40 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 56 | $23,776 | $222 |
| Short return visit (20+ min) | 224 | $18,502 | $59 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 40 | $16,159 | None |
| Vitamin d-3 level | 237 | $16,107 | $29 |
| Cystatin c (enzyme inhibitor) level | 248 | $11,130 | $18 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $10,998 | $162 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $9,610 | $128 |
| Folic acid level, serum | 242 | $8,361 | $14 |
| Ferritin (blood protein) level | 242 | $7,752 | $13 |
| Cyanocobalamin (vitamin b-12) level | 240 | $7,534 | $15 |
| Blood test, comprehensive group of blood chemicals | 253 | $6,450 | $10 |
| Insertion of needle into vein for collection of blood sample | 258 | $6,243 | $8 |
| Iron binding capacity | 244 | $4,938 | $9 |
| New patient visit (45+ min) | 37 | $4,724 | $128 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 248 | $4,575 | $8 |
| Magnesium level | 250 | $4,042 | $7 |
| Hemodialysis procedure with physician evaluation | 42 | $3,713 | $55 |
| Iron level | 244 | $3,653 | $6 |
| Red blood count automated, with additional calculations | 249 | $3,266 | $5 |
| Phosphate level | 253 | $2,889 | $5 |
| Creatinine level to test for kidney function or muscle injury | 240 | $2,887 | $5 |
| Complete ultrasound scan behind abdominal cavity | 31 | $2,758 | $86 |
| Uric acid level, blood | 235 | $2,500 | $4 |
| Complete ultrasound study of arm and leg arteries | 11 | $2,275 | $108 |
| Injection of drug or substance under skin or into muscle | 41 | $2,084 | $11 |
| Total protein level, urine | 239 | $2,046 | $4 |
| New patient visit (30+ min) | 18 | $1,451 | $81 |
| Dialysis services, per day, less than full month service (20 years or older) | 13 | $1,187 | $7 |
| Measurement of complement (immune system proteins), antigen, | 53 | $976 | $12 |
| Red blood cell concentration measurement | 31 | $258 | $2 |
| Blood count, hemoglobin | 31 | $258 | $2 |
| Hemoglobin a1c level | 16 | $171 | $10 |
2022: 37 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 67 | $104,317 | $284 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 324 | $82,989 | $57 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 71 | $42,860 | $233 |
| Short return visit (20+ min) | 245 | $39,169 | $67 |
| Home dialysis services per month (20 years or older) | 27 | $33,196 | $234 |
| Parathormone (parathyroid hormone) level | 242 | $24,777 | $40 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 53 | $21,705 | None |
| Vitamin d-3 level | 242 | $17,793 | $29 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $15,315 | $156 |
| Cystatin c (enzyme inhibitor) level | 236 | $11,176 | $18 |
| Folic acid level, serum | 232 | $8,446 | $14 |
| Ferritin (blood protein) level | 233 | $7,898 | $13 |
| Cyanocobalamin (vitamin b-12) level | 229 | $7,544 | $15 |
| Blood test, comprehensive group of blood chemicals | 249 | $6,653 | $10 |
| Dialysis services, 1 physician visit per month (20 years or older) | 16 | $6,272 | $153 |
| Telephone medical discussion with physician, 21-30 minutes | 83 | $5,559 | $57 |
| Iron binding capacity | 230 | $4,968 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 247 | $4,809 | $8 |
| Magnesium level | 247 | $4,179 | $7 |
| Iron level | 230 | $3,671 | $6 |
| Red blood count automated, with additional calculations | 244 | $3,403 | $5 |
| Phosphate level | 248 | $2,966 | $5 |
| Creatinine level to test for kidney function or muscle injury | 233 | $2,951 | $5 |
| New patient visit (30+ min) | 40 | $2,760 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,706 | $108 |
| Complete ultrasound scan behind abdominal cavity | 32 | $2,658 | $83 |
| Uric acid level, blood | 221 | $2,502 | $4 |
| Injection of drug or substance under skin or into muscle | 53 | $2,430 | $12 |
| Hemodialysis procedure with physician evaluation | 33 | $2,350 | $59 |
| Total protein level, urine | 233 | $2,111 | $4 |
| Dialysis services, per day, less than full month service (20 years or older) | 16 | $2,080 | $8 |
| Insertion of needle into vein for collection of blood sample | 247 | $1,987 | $3 |
| Short return visit (20+ min) | 13 | $1,472 | $53 |
| Measurement of complement (immune system proteins), antigen, | 41 | $960 | $12 |
| Red blood cell concentration measurement | 23 | $192 | $2 |
| Blood count, hemoglobin | 23 | $192 | $2 |
| Hemoglobin a1c level | 11 | $107 | $9 |
2021: 40 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 79 | $130,790 | $292 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 312 | $78,103 | $58 |
| Home dialysis services per month (20 years or older) | 32 | $44,606 | $239 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 60 | $28,325 | $242 |
| Telephone medical discussion with physician, 21-30 minutes | 160 | $25,732 | $93 |
| Short return visit (20+ min) | 183 | $23,949 | $68 |
| Parathormone (parathyroid hormone) level | 200 | $19,125 | $41 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 23 | $17,568 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $15,874 | $162 |
| Dialysis services, 1 physician visit per month (20 years or older) | 26 | $14,781 | $168 |
| Vitamin d-3 level | 194 | $12,916 | $29 |
| Cystatin c (enzyme inhibitor) level | 199 | $8,709 | $18 |
| Folic acid level, serum | 187 | $6,428 | $15 |
| Cyanocobalamin (vitamin b-12) level | 186 | $5,992 | $15 |
| Ferritin (blood protein) level | 179 | $5,620 | $14 |
| Blood test, comprehensive group of blood chemicals | 203 | $5,094 | $10 |
| Hemodialysis procedure with physician evaluation | 49 | $4,596 | $60 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 201 | $3,734 | $8 |
| Iron binding capacity | 181 | $3,560 | $9 |
| Complete ultrasound scan behind abdominal cavity | 37 | $3,402 | $92 |
| Magnesium level | 200 | $3,211 | $7 |
| New patient visit (30+ min) | 38 | $2,999 | $79 |
| Red blood count automated, with additional calculations | 197 | $2,625 | $6 |
| Iron level | 181 | $2,622 | $6 |
| Dialysis services, per day, less than full month service (20 years or older) | 20 | $2,350 | $8 |
| Phosphate level | 203 | $2,291 | $5 |
| Creatinine level to test for kidney function or muscle injury | 193 | $2,256 | $5 |
| Injection of drug or substance under skin or into muscle | 30 | $1,965 | $11 |
| Uric acid level, blood | 183 | $1,896 | $4 |
| Total protein level, urine | 192 | $1,612 | $4 |
| Insertion of needle into vein for collection of blood sample | 204 | $1,476 | $3 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,436 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,093 | $84 |
| Short return visit (20+ min) | 12 | $995 | $55 |
| Measurement of complement (immune system proteins), antigen, | 41 | $660 | $12 |
| Blood test, lipids (cholesterol and triglycerides) | 11 | $161 | $13 |
| Hemoglobin a1c level | 11 | $126 | $10 |
| Red blood cell concentration measurement | 12 | $82 | $2 |
| Blood count, hemoglobin | 12 | $82 | $2 |
| Urine microalbumin (protein) level | 12 | $69 | $6 |
2020: 38 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 91 | $102,813 | $222 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 391 | $95,006 | $56 |
| Home dialysis services per month (20 years or older) | 36 | $44,118 | $184 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 72 | $22,464 | $187 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 22 | $18,044 | None |
| Parathormone (parathyroid hormone) level | 150 | $15,787 | $41 |
| Short return visit (20+ min) | 171 | $15,177 | $47 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 90 | $14,022 | $156 |
| Dialysis services, 1 physician visit per month (20 years or older) | 16 | $11,850 | $143 |
| Vitamin d-3 level | 144 | $10,021 | $29 |
| Telephone medical discussion with physician, 21-30 minutes | 94 | $9,709 | $82 |
| Cystatin c (enzyme inhibitor) level | 155 | $7,355 | $18 |
| Telephone medical discussion with physician, 11-20 minutes | 96 | $7,042 | $55 |
| Hemodialysis procedure with physician evaluation | 73 | $6,441 | $57 |
| Blood test, comprehensive group of blood chemicals | 157 | $4,141 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $3,289 | $80 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 155 | $3,116 | $8 |
| Folic acid level, serum | 109 | $2,924 | $14 |
| Dialysis services, per day, less than full month service (20 years or older) | 30 | $2,839 | $6 |
| Cyanocobalamin (vitamin b-12) level | 110 | $2,789 | $15 |
| Magnesium level | 153 | $2,642 | $7 |
| Iron binding capacity | 110 | $2,501 | $9 |
| Ferritin (blood protein) level | 86 | $2,343 | $13 |
| Creatinine level to test for kidney function or muscle injury | 150 | $2,007 | $5 |
| Phosphate level | 155 | $1,912 | $5 |
| Iron level | 110 | $1,864 | $6 |
| Uric acid level, blood | 131 | $1,472 | $4 |
| Injection of drug or substance under skin or into muscle | 26 | $1,446 | $11 |
| Total protein level, urine | 148 | $1,403 | $4 |
| New patient visit (30+ min) | 17 | $1,365 | $80 |
| Insertion of needle into vein for collection of blood sample | 161 | $1,292 | $3 |
| Red blood count automated, with additional calculations | 109 | $1,213 | $6 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,187 | $108 |
| Complete ultrasound scan behind abdominal cavity | 14 | $1,082 | $77 |
| Blood test, lipids (cholesterol and triglycerides) | 29 | $548 | $13 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 37 | $335 | $9 |
| Hemoglobin a1c level | 11 | $174 | $10 |
| Urine microalbumin (protein) level | 12 | $173 | $6 |
2019: 32 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 149 | $142,224 | $223 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 292 | $57,520 | $58 |
| Home dialysis services per month (20 years or older) | 41 | $54,812 | $186 |
| Short return visit (20+ min) | 256 | $39,124 | $54 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 40 | $33,239 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 80 | $26,444 | $190 |
| Parathormone (parathyroid hormone) level | 180 | $21,263 | $45 |
| Vitamin d-3 level | 177 | $14,992 | $32 |
| Dialysis services, 1 physician visit per month (20 years or older) | 25 | $12,749 | $150 |
| Cystatin c (enzyme inhibitor) level | 181 | $8,387 | $18 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $6,552 | $84 |
| Blood test, comprehensive group of blood chemicals | 183 | $5,354 | $11 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 179 | $3,800 | $8 |
| Hemodialysis procedure with physician evaluation | 49 | $3,503 | $58 |
| Magnesium level | 178 | $3,325 | $7 |
| Dialysis services, per day, less than full month service (20 years or older) | 66 | $3,108 | $6 |
| Iron binding capacity | 129 | $3,075 | $10 |
| Injection of drug or substance under skin or into muscle | 40 | $3,028 | $14 |
| Complete ultrasound scan behind abdominal cavity | 31 | $2,882 | $93 |
| New patient visit (30+ min) | 43 | $2,567 | $60 |
| Creatinine level to test for kidney function or muscle injury | 173 | $2,399 | $6 |
| Phosphate level | 180 | $2,385 | $5 |
| Iron level | 129 | $2,277 | $7 |
| Uric acid level, blood | 165 | $2,126 | $5 |
| Total protein level, urine | 172 | $1,704 | $4 |
| Insertion of needle into vein for collection of blood sample | 190 | $1,605 | $3 |
| Acute hepatitis panel | 15 | $882 | $52 |
| Measurement of complement (immune system proteins), antigen, | 35 | $797 | $13 |
| Blood test, basic group of blood chemicals (calcium, total) | 20 | $184 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 18 | $134 | $7 |
| Red blood cell concentration measurement | 12 | $52 | $3 |
| Blood count, hemoglobin | 12 | $52 | $3 |
2018: 32 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 140 | $131,397 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 346 | $100,540 | $58 |
| Home dialysis services per month (20 years or older) | 58 | $64,318 | $188 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 68 | $21,412 | $188 |
| Short return visit (20+ min) | 202 | $21,043 | $49 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 23 | $16,880 | None |
| Parathormone (parathyroid hormone) level | 146 | $13,950 | $49 |
| Hemodialysis procedure with physician evaluation | 106 | $10,718 | $59 |
| Vitamin d-3 level | 146 | $9,867 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $7,012 | $82 |
| Dialysis services, 1 physician visit per month (20 years or older) | 24 | $5,167 | $144 |
| Cystatin c (enzyme inhibitor) level | 146 | $4,961 | $18 |
| Blood test, comprehensive group of blood chemicals | 143 | $3,311 | $13 |
| Dialysis services, per day, less than full month service (20 years or older) | 52 | $3,055 | $6 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 142 | $2,465 | $9 |
| Magnesium level | 142 | $2,165 | $8 |
| New patient visit (30+ min) | 31 | $2,135 | $69 |
| Iron binding capacity | 109 | $2,084 | $10 |
| Injection of drug or substance under skin or into muscle | 23 | $2,079 | $17 |
| Phosphate level | 149 | $1,595 | $6 |
| Iron level | 109 | $1,552 | $8 |
| Creatinine level to test for kidney function or muscle injury | 139 | $1,517 | $6 |
| Uric acid level, blood | 137 | $1,386 | $5 |
| Total protein level, urine | 135 | $1,049 | $4 |
| Insertion of needle into vein for collection of blood sample | 157 | $1,006 | $3 |
| Acute hepatitis panel | 11 | $753 | $54 |
| Measurement of complement (immune system proteins), antigen, | 21 | $682 | $15 |
| Cyanocobalamin (vitamin b-12) level | 14 | $292 | $18 |
| Folic acid level, serum | 14 | $285 | $18 |
| Hemoglobin a1c level | 14 | $188 | $12 |
| Blood test, basic group of blood chemicals (calcium, total) | 16 | $184 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 15 | $157 | $7 |
2017: 34 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 125 | $151,670 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 331 | $99,256 | $58 |
| Home dialysis services per month (20 years or older) | 65 | $76,694 | $187 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 83 | $29,585 | $191 |
| Short return visit (20+ min) | 244 | $26,644 | $53 |
| Hemodialysis procedure with physician evaluation | 120 | $16,285 | $59 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 25 | $13,519 | None |
| Parathormone (parathyroid hormone) level | 97 | $9,381 | $55 |
| Dialysis services, 1 physician visit per month (20 years or older) | 25 | $8,020 | $146 |
| Dialysis services, per day, less than full month service (20 years or older) | 39 | $6,564 | $6 |
| Vitamin d-3 level | 92 | $6,490 | $40 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $5,077 | $85 |
| New patient visit (30+ min) | 64 | $4,849 | $76 |
| Cystatin c (enzyme inhibitor) level | 99 | $3,127 | $18 |
| Dialysis procedure including 1 evaluation | 18 | $2,865 | $70 |
| Injection of drug or substance under skin or into muscle | 27 | $2,554 | $21 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 106 | $1,913 | $10 |
| Magnesium level | 96 | $1,496 | $9 |
| Iron binding capacity | 84 | $1,451 | $9 |
| Complete ultrasound scan behind abdominal cavity | 15 | $1,426 | $95 |
| Iron level | 85 | $1,357 | $9 |
| Folic acid level, serum | 53 | $1,305 | $20 |
| Blood test, comprehensive group of blood chemicals | 99 | $1,254 | $7 |
| Cyanocobalamin (vitamin b-12) level | 46 | $1,176 | $20 |
| Creatinine level to test for kidney function or muscle injury | 94 | $1,114 | $7 |
| Total protein level, urine | 94 | $779 | $5 |
| Phosphate level | 100 | $700 | $4 |
| Insertion of needle into vein for collection of blood sample | 121 | $697 | $3 |
| Uric acid level, blood | 89 | $576 | $4 |
| Hemoglobin a1c level | 34 | $458 | $13 |
| Ferritin (blood protein) level | 11 | $422 | $18 |
| Blood test, basic group of blood chemicals (calcium, total) | 32 | $416 | $11 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 14 | $200 | $9 |
| Blood test, lipids (cholesterol and triglycerides) | 19 | $190 | $9 |
2016: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 165 | $117,458 | $224 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 217 | $59,306 | $57 |
| Home dialysis services per month (20 years or older) | 49 | $29,008 | $191 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 64 | $24,427 | $186 |
| Short return visit (20+ min) | 169 | $14,673 | $52 |
| Hemodialysis procedure with physician evaluation | 76 | $7,059 | $58 |
| Dialysis services, 1 physician visit per month (20 years or older) | 24 | $5,402 | $146 |
| Dialysis procedure including 1 evaluation | 19 | $4,826 | $69 |
| New patient visit (30+ min) | 42 | $3,250 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,075 | $102 |
| Dialysis services, per day, less than full month service (20 years or older) | 23 | $3,060 | $6 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,055 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,154 | $82 |
2015: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 191 | $115,140 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 182 | $44,904 | $56 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 103 | $34,141 | $186 |
| Return visit (30+ min) | 300 | $27,675 | $73 |
| Dialysis services, 1 physician visit per month (20 years or older) | 59 | $9,820 | $140 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $7,689 | $103 |
| Hemodialysis procedure with physician evaluation | 67 | $7,204 | $56 |
| New patient visit (45+ min) | 43 | $4,583 | $107 |
| Short return visit (20+ min) | 59 | $4,106 | $59 |
| Dialysis procedure including 1 evaluation | 11 | $3,578 | $70 |
| Short return visit (20+ min) | 54 | $2,456 | $32 |
| New patient visit (30+ min) | 27 | $2,311 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,817 | $83 |
| New patient visit (15+ min) | 14 | $863 | $62 |
| New patient visit (15+ min) | 14 | $378 | $27 |
2014: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 216 | $62,442 | $54 |
| Return visit (30+ min) | 272 | $36,291 | $75 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | $19,737 | $179 |
| Hemodialysis procedure with physician evaluation | 108 | $17,177 | $55 |
| New patient visit (45+ min) | 124 | $13,590 | $110 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 116 | $13,271 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $10,221 | $78 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 12 | $9,407 | $214 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,156 | $148 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $3,583 | $138 |
| Short return visit (20+ min) | 59 | $3,504 | $39 |
| New patient visit (15+ min) | 21 | $790 | $38 |
2013: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $15,686 | $52 |
| Return visit (30+ min) | 70 | $6,260 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,493 | $100 |
| Hemodialysis procedure with physician evaluation | 21 | $2,392 | $53 |
| New patient visit (45+ min) | 17 | $1,963 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,614 | $147 |
Medicaid work
$194,339 in 2024
Medicaid paid $194,339 for 6,902 billed services this clinician did in 2024, up to 113 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 702 | $83,073 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 377 | $37,563 |
| Return visit (30+ min) | 797 | $23,910 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,186 | $17,090 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 237 | $14,225 |
| Short return visit (20+ min) | 1,243 | $5,115 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 42 | $2,516 |
| 1ST HOSP IP/OBS HIGH 75 | 104 | $2,502 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 30 | $2,106 |
| Parathormone (parathyroid hormone) | 79 | $1,045 |
| Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time | 12 | $864 |
| Measurement of vitamin D 25 hydroxy | 81 | $622 |
| 2024 | 6,902 | 36 | 113 | $194,339 |
| 2023 | 6,665 | 29 | 72 | $143,675 |
| 2022 | 5,176 | 26 | 65 | $123,590 |
| 2021 | 4,576 | 24 | 47 | $93,661 |
| 2020 | 9,333 | 30 | 51 | $128,219 |
| 2019 | 7,704 | 23 | 71 | $75,908 |
| 2018 | 6,620 | 8 | 68 | $49,671 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 497 | $52,406 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 397 | $41,790 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 875 | $13,665 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 219 | $10,312 |
| Short return visit (20+ min) | 1,118 | $6,609 |
| Return visit (30+ min) | 321 | $4,609 |
| Parathormone (parathyroid hormone) | 181 | $2,435 |
| Measurement of vitamin D 25 hydroxy | 178 | $1,667 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 17 | $1,159 |
| Measurement of cystatin C | 168 | $970 |
| VITAMIN B-12 | 155 | $929 |
| 1ST HOSP IP/OBS HIGH 75 | 34 | $862 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 302 | $34,559 |
| Clinic visit/encounter, all-inclusive | 307 | $31,919 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,114 | $18,538 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 123 | $8,366 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 103 | $6,827 |
| Short return visit (20+ min) | 951 | $6,676 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 75 | $4,726 |
| Parathormone (parathyroid hormone) | 148 | $2,067 |
| Measurement of vitamin D 25 hydroxy | 149 | $1,470 |
| 1ST HOSP IP/OBS HIGH 75 | 23 | $1,157 |
| VITAMIN B-12 | 98 | $1,109 |
| Measurement of cystatin C | 155 | $953 |
2021
| Clinic visit/encounter, all-inclusive | 470 | $46,532 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 207 | $19,552 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 912 | $14,555 |
| Short return visit (20+ min) | 856 | $5,747 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 79 | $2,711 |
| VITAMIN B-12 | 56 | $856 |
| Measurement of folic acid in serum | 56 | $763 |
| Parathormone (parathyroid hormone) | 58 | $711 |
| COMPREHENSIVE METABOLIC PANEL | 56 | $525 |
| Measurement of cystatin C | 54 | $260 |
| Measurement of vitamin D 25 hydroxy | 83 | $230 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 56 | $197 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 485 | $37,357 |
| Clinic visit/encounter, all-inclusive | 429 | $32,756 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 985 | $20,900 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 247 | $11,255 |
| Short return visit (20+ min) | 850 | $7,092 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 77 | $4,019 |
| Measurement of vitamin D 25 hydroxy | 199 | $2,868 |
| Parathormone (parathyroid hormone) | 198 | $1,918 |
| COMPREHENSIVE METABOLIC PANEL | 202 | $1,311 |
| VITAMIN B-12 | 66 | $1,081 |
| Measurement of ferritin | 65 | $774 |
| Phosphorus inorganic (phosphate) | 200 | $765 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 643 | $36,550 |
| Clinic visit/encounter, all-inclusive | 136 | $10,260 |
| Short return visit (20+ min) | 555 | $7,059 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 292 | $4,697 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 78 | $3,990 |
| Parathormone (parathyroid hormone) | 173 | $2,388 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 199 | $2,087 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 12 | $1,595 |
| Measurement of vitamin D 25 hydroxy | 175 | $1,549 |
| COMPREHENSIVE METABOLIC PANEL | 162 | $1,295 |
| Creatinine; other source | 160 | $776 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 147 | $485 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 587 | $20,982 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 965 | $15,118 |
| Clinic visit/encounter, all-inclusive | 103 | $7,534 |
| Short return visit (20+ min) | 255 | $3,110 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 27 | $1,849 |
| Iron sucrose injection | 266 | $1,025 |
| Injection, doxercalciferol, 1 mcg | 59 | $54 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 4,358 | $0 |
Drugs they prescribed that Part D paid
$1,807,447
Pharmacies billed $1,807,447 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
5,424 generic and fewer than 11 brand-name prescriptions · $1,807,447 in drug cost · 194 antibiotic prescriptions to 138 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Acthar | 11 | $451,751 | $41,068 |
| Velphoro | 82 | $261,338 | $3,187 |
| Jynarque | 12 | $232,764 | $19,397 |
| Veltassa | 145 | $205,761 | $1,419 |
| Sevelamer | 31 | $97,085 | $3,132 |
See all 70 drugs
| Acthar | 11 | $451,751 | $41,068 |
| Velphoro | 82 | $261,338 | $3,187 |
| Jynarque | 12 | $232,764 | $19,397 |
| Veltassa | 145 | $205,761 | $1,419 |
| Sevelamer | 31 | $97,085 | $3,132 |
| Lokelma | 73 | $79,412 | $1,088 |
| Farxiga | 69 | $72,672 | $1,053 |
| Prosol | 230 | $48,170 | $209 |
| Sevelamer Carbonate | 125 | $37,121 | $297 |
| Cinacalcet | 144 | $35,895 | $249 |
| Procrit | 12 | $25,359 | $2,113 |
| Clinolipid | 77 | $23,135 | $300 |
| Lactulose | 49 | $12,003 | $245 |
| Calcitriol | 590 | $11,412 | $19 |
| Calcium Acetate | 89 | $11,171 | $126 |
| Tradjenta | 16 | $8,504 | $532 |
| Febuxostat | 45 | $8,037 | $179 |
| Potassium Citrate Er | 77 | $7,371 | $96 |
| Doxazosin Mesylate | 451 | $7,160 | $16 |
| Midodrine | 42 | $4,939 | $118 |
| Carvedilol | 490 | $4,196 | $9 |
| Bumetanide | 52 | $3,014 | $58 |
| Allopurinol | 418 | $2,891 | $7 |
| Nifedipine Er | 46 | $2,883 | $63 |
| Losartan | 301 | $2,593 | $9 |
| Potassium Chloride | 66 | $2,587 | $39 |
| Metolazone | 23 | $2,221 | $97 |
| Amlodipine Besylate | 457 | $2,167 | $5 |
| Furosemide | 275 | $2,163 | $8 |
| Labetalol | 23 | $1,693 | $74 |
| Hydralazine | 81 | $1,440 | $18 |
| Triazolam | 15 | $1,231 | $82 |
| Isosorbide Mononitrate Er | 86 | $1,228 | $14 |
| Metoprolol | 67 | $1,184 | $18 |
| Ondansetron Odt | 26 | $1,172 | $45 |
| Tamsulosin | 83 | $1,155 | $14 |
| Fluconazole | 17 | $920 | $54 |
| Rosuvastatin | 28 | $871 | $31 |
| Lisinopril | 116 | $822 | $7 |
| Gentamicin Sulfate | 19 | $716 | $38 |
| Minoxidil | 20 | $654 | $33 |
| Atorvastatin | 99 | $555 | $6 |
| Metoprolol | 68 | $549 | $8 |
| Pantoprazole | 40 | $521 | $13 |
| Gabapentin | 52 | $500 | $10 |
| Olmesartan Medoxomil | 16 | $500 | $31 |
| Glipizide | 51 | $473 | $9 |
| Levothyroxine | 18 | $382 | $21 |
| Ropinirole | 37 | $277 | $7 |
| Famotidine | 46 | $261 | $6 |
| Cefdinir | 50 | $228 | $5 |
| Terazosin | 13 | $214 | $16 |
| Chlorthalidone | 13 | $214 | $16 |
| Vitamin D2 | 12 | $206 | $17 |
| Omeprazole | 23 | $184 | $8 |
| Hydrochlorothiazide | 15 | $182 | $12 |
| Clonidine | 25 | $179 | $7 |
| Spironolactone | 18 | $173 | $10 |
| Glipizide Er | 18 | $160 | $9 |
| Prednisone | 23 | $145 | $6 |
| Ciprofloxacin | 89 | $138 | $2 |
| Metformin | 19 | $119 | $6 |
| Hydroxyzine | 35 | $119 | $3 |
| Atenolol | 13 | $112 | $9 |
| Clopidogrel | 15 | $83 | $6 |
| Benazepril | 14 | $60 | $4 |
| Temazepam | 20 | $55 | $3 |
| Azithromycin | 16 | $36 | $2 |
| Alprazolam | 25 | $31 | $1 |
| Cephalexin | 13 | $30 | $2 |
Year by year
| 2024 | 6,367 | 833 | None | None | $1,807,447 |
| 2023 | 4,866 | 611 | None | 17% | $1,720,113 |
| 2022 | 4,062 | 527 | None | 17% | $1,463,326 |
| 2021 | 4,272 | 479 | None | 21% | $2,278,325 |
| 2020 | 4,946 | 459 | 0% (12) | 26% | $1,827,234 |
| 2019 | 5,477 | 491 | 0% (17) | 27% | $2,446,190 |
| 2018 | 5,944 | 459 | 0% (13) | 29% | $1,926,527 |
| 2017 | 6,766 | 545 | 1% (49) | 31% | $2,177,140 |
| 2016 | 3,990 | 463 | 1% (36) | 32% | $1,105,585 |
| 2015 | 4,971 | 535 | 3% (126) | 35% | $1,172,585 |
| 2014 | 3,817 | 369 | 6% (225) | 30% | $628,817 |
| 2013 | 242 | 110 | 15% (37) | 30% | $31,838 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 62 drugs
| Veltassa | 116 | $216,901 | $1,870 |
| Velphoro | 49 | $216,745 | $4,423 |
| Sevelamer Carbonate | 139 | $100,937 | $726 |
| Cinacalcet | 87 | $97,493 | $1,121 |
| Lokelma | 44 | $58,791 | $1,336 |
| Clinolipid | 163 | $48,729 | $299 |
| Prosol | 211 | $34,127 | $162 |
| Lactulose | 30 | $30,519 | $1,017 |
| Renvela | 16 | $28,727 | $1,795 |
| Febuxostat | 54 | $21,007 | $389 |
| Calcitriol | 461 | $14,802 | $32 |
| Doxazosin Mesylate | 317 | $12,150 | $38 |
| Midodrine | 48 | $9,680 | $202 |
| Calcium Acetate | 72 | $9,574 | $133 |
| Carvedilol | 370 | $8,830 | $24 |
| Potassium Citrate Er | 53 | $6,195 | $117 |
| Allopurinol | 387 | $6,169 | $16 |
| Amlodipine Besylate | 323 | $5,972 | $18 |
| Bumetanide | 55 | $4,974 | $90 |
| Furosemide | 204 | $4,649 | $23 |
| Nifedipine Er | 27 | $4,527 | $168 |
| Losartan | 167 | $3,948 | $24 |
| Labetalol | 11 | $3,208 | $292 |
| Hydralazine | 55 | $2,663 | $48 |
| Triazolam | 20 | $2,424 | $121 |
| Potassium Chloride | 32 | $2,201 | $69 |
| Atorvastatin | 72 | $2,009 | $28 |
| Tamsulosin | 59 | $1,858 | $31 |
| Metoprolol | 60 | $1,660 | $28 |
| Metolazone | 12 | $1,580 | $132 |
| Metoprolol | 66 | $1,487 | $23 |
| Lisinopril | 86 | $1,357 | $16 |
| Gentamicin Sulfate | 18 | $1,264 | $70 |
| Fluconazole | 11 | $1,258 | $114 |
| Isosorbide Mononitrate Er | 32 | $1,109 | $35 |
| Valsartan | 12 | $842 | $70 |
| Rosuvastatin | 14 | $630 | $45 |
| Pantoprazole | 29 | $622 | $21 |
| Gabapentin | 39 | $588 | $15 |
| Clopidogrel | 21 | $584 | $28 |
| Ropinirole | 11 | $581 | $53 |
| Lidocaine-Prilocaine | 13 | $561 | $43 |
| Clonidine | 18 | $543 | $30 |
| Levothyroxine | 24 | $502 | $21 |
| Glipizide | 32 | $484 | $15 |
| Terazosin | 14 | $420 | $30 |
| Ondansetron Odt | 12 | $407 | $34 |
| Omeprazole | 22 | $401 | $18 |
| Lovastatin | 11 | $361 | $33 |
| Cephalexin | 17 | $290 | $17 |
| Cefdinir | 33 | $268 | $8 |
| Simvastatin | 12 | $261 | $22 |
| Famotidine | 13 | $240 | $18 |
| Temazepam | 27 | $240 | $9 |
| Spironolactone | 14 | $238 | $17 |
| Citalopram Hbr | 11 | $227 | $21 |
| Prednisone | 21 | $223 | $11 |
| Ciprofloxacin | 49 | $179 | $4 |
| Zolpidem | 11 | $147 | $13 |
| Alprazolam | 26 | $133 | $5 |
| Hydroxyzine | 12 | $132 | $11 |
| Azithromycin | 13 | $46 | $4 |
2022: 64 drugs
| Velphoro | 56 | $255,574 | $4,564 |
| Sevelamer Carbonate | 144 | $155,368 | $1,079 |
| Veltassa | 49 | $96,697 | $1,973 |
| Cinacalcet | 81 | $78,270 | $966 |
| Lokelma | 47 | $59,446 | $1,265 |
| Renvela | 25 | $46,271 | $1,851 |
| Clinolipid | 136 | $41,119 | $302 |
| Prosol | 112 | $20,754 | $185 |
| Rayaldee | 15 | $19,049 | $1,270 |
| Febuxostat | 75 | $17,170 | $229 |
| Januvia | 13 | $10,658 | $820 |
| Clinisol | 69 | $9,802 | $142 |
| Calcitriol | 327 | $9,402 | $29 |
| Midodrine | 54 | $9,165 | $170 |
| Calcium Acetate | 68 | $8,788 | $129 |
| Basaglar Kwikpen U-100 | 11 | $7,131 | $648 |
| Nifedipine Er | 39 | $6,647 | $170 |
| Doxazosin Mesylate | 280 | $6,197 | $22 |
| Lantus Solostar | 11 | $5,810 | $528 |
| Allopurinol | 352 | $5,093 | $14 |
| Carvedilol | 275 | $4,430 | $16 |
| Potassium Citrate Er | 21 | $3,938 | $188 |
| Bumetanide | 38 | $3,446 | $91 |
| Tacrolimus | 14 | $2,869 | $205 |
| Potassium Chloride | 34 | $2,414 | $71 |
| Amlodipine Besylate | 237 | $2,385 | $10 |
| Furosemide | 215 | $2,087 | $10 |
| Fluconazole | 11 | $1,977 | $180 |
| Metolazone | 16 | $1,893 | $118 |
| Losartan | 135 | $1,716 | $13 |
| Rosuvastatin | 23 | $1,678 | $73 |
| Tamsulosin | 50 | $1,422 | $28 |
| Hydralazine | 45 | $1,252 | $28 |
| Ondansetron Odt | 12 | $1,132 | $94 |
| Atorvastatin | 62 | $1,061 | $17 |
| Lactulose | 17 | $956 | $56 |
| Metoprolol | 33 | $910 | $28 |
| Lisinopril | 67 | $851 | $13 |
| Gabapentin | 26 | $701 | $27 |
| Gentamicin Sulfate | 12 | $674 | $56 |
| Ropinirole | 14 | $656 | $47 |
| Minoxidil | 15 | $582 | $39 |
| Chlorthalidone | 19 | $564 | $30 |
| Sodium Chloride | 26 | $536 | $21 |
| Metoprolol | 44 | $450 | $10 |
| Isosorbide Mononitrate Er | 21 | $426 | $20 |
| Famotidine | 17 | $378 | $22 |
| Glipizide | 19 | $365 | $19 |
| Levothyroxine | 29 | $363 | $13 |
| Omeprazole | 22 | $324 | $15 |
| Prednisone | 22 | $282 | $13 |
| Clopidogrel | 19 | $280 | $15 |
| Clonidine | 19 | $255 | $13 |
| Pantoprazole | 21 | $249 | $12 |
| Irbesartan | 13 | $224 | $17 |
| Ciprofloxacin | 35 | $203 | $6 |
| Temazepam | 17 | $176 | $10 |
| Spironolactone | 15 | $167 | $11 |
| Simvastatin | 11 | $158 | $14 |
| Metformin | 13 | $152 | $12 |
| Cefdinir | 15 | $113 | $8 |
| Metoclopramide | 12 | $83 | $7 |
| Hydroxyzine | 15 | $57 | $4 |
| Levofloxacin | 12 | $51 | $4 |
2021: 62 drugs
| Acthar | 22 | $1,349,565 | $61,344 |
| Velphoro | 81 | $241,625 | $2,983 |
| Veltassa | 83 | $117,088 | $1,411 |
| Sevelamer Carbonate | 155 | $82,984 | $535 |
| Clinolipid | 203 | $55,712 | $274 |
| Cinacalcet | 75 | $51,558 | $687 |
| Lokelma | 30 | $41,385 | $1,379 |
| Renvela | 21 | $39,965 | $1,903 |
| Rayaldee | 25 | $37,942 | $1,518 |
| Febuxostat | 125 | $29,496 | $236 |
| Clinisol | 85 | $17,036 | $200 |
| Prosol | 115 | $16,740 | $146 |
| Calcitriol | 341 | $12,572 | $37 |
| Lantus Solostar | 21 | $10,206 | $486 |
| Calcium Acetate | 74 | $9,646 | $130 |
| Midodrine | 57 | $8,078 | $142 |
| Doxazosin Mesylate | 206 | $4,471 | $22 |
| Nifedipine Er | 43 | $4,087 | $95 |
| Allopurinol | 239 | $3,445 | $14 |
| Carvedilol | 248 | $3,326 | $13 |
| Bumetanide | 26 | $2,309 | $89 |
| Losartan | 130 | $1,945 | $15 |
| Amlodipine Besylate | 228 | $1,621 | $7 |
| Lactulose | 22 | $1,437 | $65 |
| Furosemide | 204 | $1,284 | $6 |
| Minoxidil | 45 | $1,268 | $28 |
| Metolazone | 11 | $1,252 | $114 |
| Atorvastatin | 55 | $1,211 | $22 |
| Gentamicin Sulfate | 21 | $1,149 | $55 |
| Potassium Chloride | 44 | $1,148 | $26 |
| Hydralazine | 38 | $957 | $25 |
| Tamsulosin | 43 | $942 | $22 |
| Chlorthalidone | 25 | $810 | $32 |
| Irbesartan | 15 | $802 | $53 |
| Lisinopril | 81 | $774 | $10 |
| Mycophenolate Mofetil | 14 | $691 | $49 |
| Sodium Chloride | 25 | $617 | $25 |
| Famotidine | 42 | $582 | $14 |
| Levothyroxine | 35 | $575 | $16 |
| Ropinirole | 32 | $552 | $17 |
| Pravastatin | 26 | $542 | $21 |
| Ondansetron | 14 | $521 | $37 |
| Metoprolol | 24 | $492 | $20 |
| Spironolactone | 23 | $406 | $18 |
| Lidocaine-Prilocaine | 18 | $404 | $22 |
| Isosorbide Mononitrate Er | 18 | $402 | $22 |
| Clonidine | 33 | $333 | $10 |
| Metoprolol | 36 | $302 | $8 |
| Gabapentin | 34 | $280 | $8 |
| Omeprazole | 26 | $268 | $10 |
| Pantoprazole | 24 | $263 | $11 |
| Clopidogrel | 15 | $256 | $17 |
| Atenolol | 21 | $210 | $10 |
| Klor-Con M20 | 14 | $203 | $14 |
| Cefdinir | 15 | $165 | $11 |
| Alprazolam | 16 | $124 | $8 |
| Temazepam | 14 | $120 | $9 |
| Zolpidem | 13 | $91 | $7 |
| Ciprofloxacin | 39 | $87 | $2 |
| Cephalexin | 13 | $70 | $5 |
| Levofloxacin | 13 | $63 | $5 |
| Hydroxyzine | 15 | $61 | $4 |
2020: 71 drugs
| Acthar | 17 | $806,479 | $47,440 |
| Velphoro | 75 | $214,007 | $2,853 |
| Veltassa | 120 | $131,858 | $1,099 |
| Renvela | 49 | $89,179 | $1,820 |
| Rayaldee | 40 | $74,264 | $1,857 |
| Sevelamer Carbonate | 207 | $71,088 | $343 |
| Prosol | 360 | $63,409 | $176 |
| Cinacalcet | 104 | $58,875 | $566 |
| Febuxostat | 116 | $40,734 | $351 |
| Auryxia | 18 | $20,277 | $1,127 |
| Clinisol | 91 | $19,112 | $210 |
| Clinolipid | 59 | $15,491 | $263 |
| Lantus Solostar | 28 | $13,052 | $466 |
| Eliquis | 16 | $12,634 | $790 |
| Intralipid | 52 | $12,052 | $232 |
| Calcitriol | 328 | $11,220 | $34 |
| Januvia | 16 | $9,762 | $610 |
| Levemir Flextouch | 20 | $7,979 | $399 |
| Calcium Acetate | 72 | $7,581 | $105 |
| Midodrine | 45 | $5,061 | $112 |
| Doxazosin Mesylate | 188 | $4,287 | $23 |
| Bumetanide | 36 | $3,405 | $95 |
| Nifedipine Er | 38 | $3,177 | $84 |
| Bystolic | 12 | $3,109 | $259 |
| Allopurinol | 250 | $2,806 | $11 |
| Carvedilol | 245 | $2,499 | $10 |
| Potassium Chloride | 72 | $2,340 | $33 |
| Diltiazem 12hr Er | 12 | $2,315 | $193 |
| Potassium Citrate Er | 14 | $2,058 | $147 |
| Gentamicin Sulfate | 30 | $1,803 | $60 |
| Metolazone | 16 | $1,761 | $110 |
| Hydralazine | 109 | $1,686 | $15 |
| Furosemide | 198 | $1,483 | $7 |
| Losartan | 118 | $1,407 | $12 |
| Lactulose | 19 | $1,380 | $73 |
| Amlodipine Besylate | 210 | $1,275 | $6 |
| Levothyroxine | 55 | $1,270 | $23 |
| Irbesartan | 21 | $1,230 | $59 |
| Metoprolol | 46 | $1,120 | $24 |
| Atorvastatin | 72 | $1,104 | $15 |
| Minoxidil | 41 | $1,095 | $27 |
| Lisinopril | 111 | $999 | $9 |
| Ondansetron | 29 | $887 | $31 |
| Famotidine | 59 | $703 | $12 |
| Olmesartan Medoxomil | 22 | $627 | $29 |
| Chlorthalidone | 11 | $595 | $54 |
| Omeprazole | 34 | $540 | $16 |
| Pantoprazole | 51 | $536 | $11 |
| Diltiazem | 24 | $520 | $22 |
| Lidocaine-Prilocaine | 24 | $514 | $21 |
| Sodium Chloride | 17 | $505 | $30 |
| Clonidine | 43 | $429 | $10 |
| Ropinirole | 36 | $416 | $12 |
| Tamsulosin | 37 | $412 | $11 |
| Metoprolol | 62 | $377 | $6 |
| Clopidogrel | 20 | $358 | $18 |
| Pravastatin | 19 | $356 | $19 |
| Megestrol Acetate | 13 | $284 | $22 |
| Montelukast | 25 | $234 | $9 |
| Temazepam | 17 | $154 | $9 |
| Glipizide | 20 | $132 | $7 |
| Cefdinir | 18 | $119 | $7 |
| Gabapentin | 21 | $117 | $6 |
| Alprazolam | 22 | $116 | $5 |
| Ondansetron Odt | 11 | $113 | $10 |
| Cartia Xt | 12 | $111 | $9 |
| Hydroxyzine | 15 | $108 | $7 |
| Atenolol | 13 | $105 | $8 |
| Ciprofloxacin | 33 | $102 | $3 |
| Citalopram Hbr | 24 | $83 | $3 |
| Prednisone | 16 | $55 | $3 |
2019: 88 drugs
| Acthar | 28 | $1,516,233 | $54,151 |
| Renvela | 63 | $113,314 | $1,799 |
| Sevelamer Carbonate | 191 | $100,042 | $524 |
| Prosol | 408 | $90,029 | $221 |
| Uloric | 137 | $74,163 | $541 |
| Veltassa | 70 | $70,363 | $1,005 |
| Velphoro | 32 | $69,082 | $2,159 |
| Sensipar | 42 | $43,003 | $1,024 |
| Rayaldee | 22 | $38,373 | $1,744 |
| Febuxostat | 73 | $31,068 | $426 |
| Clinisol | 168 | $26,290 | $156 |
| Lantus Solostar | 49 | $20,190 | $412 |
| Cinacalcet | 40 | $19,051 | $476 |
| Trulicity | 18 | $18,074 | $1,004 |
| Januvia | 23 | $16,916 | $735 |
| Levemir Flextouch | 31 | $13,498 | $435 |
| Auryxia | 12 | $12,934 | $1,078 |
| Eliquis | 16 | $12,684 | $793 |
| Calcitriol | 323 | $11,986 | $37 |
| Novolog | 11 | $9,419 | $856 |
| Tradjenta | 13 | $8,594 | $661 |
| Intralipid | 37 | $8,480 | $229 |
| Calcium Acetate | 67 | $5,093 | $76 |
| Nexium | 12 | $3,734 | $311 |
| Midodrine | 39 | $3,521 | $90 |
| Doxazosin Mesylate | 146 | $3,275 | $22 |
| Allopurinol | 198 | $2,631 | $13 |
| Dextrose in Water | 149 | $2,623 | $18 |
| Carvedilol | 201 | $2,518 | $13 |
| Olmesartan Medoxomil | 28 | $2,514 | $90 |
| Bystolic | 13 | $2,460 | $189 |
| Nifedipine Er | 57 | $2,362 | $41 |
| Potassium Chloride | 67 | $2,074 | $31 |
| Bumetanide | 26 | $1,973 | $76 |
| Labetalol | 28 | $1,920 | $69 |
| Hydralazine | 118 | $1,863 | $16 |
| Furosemide | 231 | $1,832 | $8 |
| Metoprolol | 60 | $1,741 | $29 |
| Levothyroxine | 69 | $1,714 | $25 |
| Gentamicin Sulfate | 27 | $1,543 | $57 |
| Atorvastatin | 108 | $1,521 | $14 |
| Rosuvastatin | 11 | $1,449 | $132 |
| Losartan | 169 | $1,420 | $8 |
| Minoxidil | 57 | $1,373 | $24 |
| Amlodipine Besylate | 154 | $1,144 | $7 |
| Clonidine | 56 | $961 | $17 |
| Lactulose | 23 | $958 | $42 |
| Chlorthalidone | 22 | $793 | $36 |
| Omeprazole | 37 | $743 | $20 |
| Lisinopril | 115 | $730 | $6 |
| Ultra-Fine Nano Pen Needle | 13 | $693 | $53 |
| Pravastatin | 23 | $688 | $30 |
| Irbesartan | 21 | $663 | $32 |
| Famotidine | 75 | $623 | $8 |
| Metoprolol | 97 | $622 | $6 |
| Ondansetron | 30 | $608 | $20 |
| Pantoprazole | 48 | $533 | $11 |
| Fluconazole | 11 | $523 | $48 |
| Oxybutynin Chloride | 16 | $477 | $30 |
| Ultra-Fine Mini Pen Needle | 12 | $470 | $39 |
| Diltiazem | 37 | $443 | $12 |
| Ropinirole | 39 | $438 | $11 |
| Tamsulosin | 36 | $417 | $12 |
| Esomeprazole Magnesium | 15 | $402 | $27 |
| Amitriptyline | 22 | $369 | $17 |
| Prednisone | 32 | $365 | $11 |
| Clopidogrel | 19 | $357 | $19 |
| Glipizide Er | 32 | $354 | $11 |
| Lidocaine-Prilocaine | 19 | $316 | $17 |
| Glipizide | 37 | $306 | $8 |
| Montelukast | 28 | $302 | $11 |
| Megestrol Acetate | 14 | $272 | $19 |
| Gabapentin | 31 | $261 | $8 |
| Ciprofloxacin | 58 | $257 | $4 |
| Azithromycin | 25 | $188 | $8 |
| Benazepril | 22 | $161 | $7 |
| Simvastatin | 19 | $151 | $8 |
| Cephalexin | 29 | $145 | $5 |
| Metoclopramide | 23 | $141 | $6 |
| Hydroxyzine | 11 | $136 | $12 |
| Alprazolam | 15 | $107 | $7 |
| Citalopram Hbr | 21 | $106 | $5 |
| Levofloxacin | 15 | $102 | $7 |
| Temazepam | 17 | $100 | $6 |
| Spironolactone | 11 | $91 | $8 |
| Sertraline | 11 | $91 | $8 |
| Zolpidem | 12 | $88 | $7 |
| Cefdinir | 19 | $62 | $3 |
2018: 93 drugs
| H.P. Acthar | 14 | $837,656 | $59,833 |
| Renvela | 207 | $341,023 | $1,647 |
| Sevelamer Carbonate | 169 | $122,200 | $723 |
| Uloric | 265 | $121,700 | $459 |
| Prosol | 358 | $73,259 | $205 |
| Sensipar | 56 | $67,105 | $1,198 |
| Veltassa | 37 | $30,428 | $822 |
| Trulicity | 32 | $30,302 | $947 |
| Lantus Solostar | 51 | $22,862 | $448 |
| Tradjenta | 33 | $19,192 | $582 |
| Auryxia | 18 | $18,892 | $1,050 |
| Levemir Flextouch | 29 | $17,041 | $588 |
| Januvia | 16 | $12,915 | $807 |
| Calcitriol | 345 | $8,852 | $26 |
| Eliquis | 13 | $6,556 | $504 |
| Novolog | 15 | $5,432 | $362 |
| Calcium Acetate | 87 | $4,801 | $55 |
| Vascepa | 28 | $4,378 | $156 |
| Humalog Kwikpen U-100 | 11 | $4,340 | $395 |
| Lantus | 14 | $3,989 | $285 |
| Nexium | 13 | $3,493 | $269 |
| Midodrine | 32 | $3,274 | $102 |
| Clinisol | 18 | $3,014 | $167 |
| Clonidine | 21 | $2,468 | $118 |
| Gentamicin Sulfate | 54 | $2,349 | $44 |
| Atorvastatin | 163 | $2,180 | $13 |
| Potassium Chloride | 81 | $2,044 | $25 |
| Labetalol | 42 | $2,010 | $48 |
| Nifedipine Er | 56 | $1,946 | $35 |
| Metoprolol | 71 | $1,920 | $27 |
| Hydralazine | 187 | $1,885 | $10 |
| Losartan | 273 | $1,873 | $7 |
| Megestrol Acetate | 52 | $1,681 | $32 |
| Allopurinol | 150 | $1,616 | $11 |
| Bystolic | 12 | $1,592 | $133 |
| Levothyroxine | 61 | $1,550 | $25 |
| Doxazosin Mesylate | 55 | $1,450 | $26 |
| Metolazone | 17 | $1,307 | $77 |
| Ultra-Fine Short Pen Needle | 26 | $1,295 | $50 |
| Esomeprazole Magnesium | 12 | $1,293 | $108 |
| Bumetanide | 15 | $1,246 | $83 |
| Carvedilol | 163 | $1,196 | $7 |
| Fluconazole | 14 | $1,144 | $82 |
| Amlodipine Besylate | 225 | $1,096 | $5 |
| Furosemide | 213 | $1,088 | $5 |
| Minoxidil | 57 | $1,057 | $19 |
| Tamsulosin | 72 | $986 | $14 |
| Chlorthalidone | 23 | $908 | $39 |
| Pravastatin | 43 | $821 | $19 |
| Ondansetron | 43 | $791 | $18 |
| Omeprazole | 73 | $742 | $10 |
| Clonidine | 69 | $725 | $11 |
| Pantoprazole | 62 | $710 | $11 |
| Ultra-Fine Nano Pen Needle | 16 | $708 | $44 |
| Metoprolol | 115 | $692 | $6 |
| Ultra-Fine Mini Pen Needle | 15 | $614 | $41 |
| Dextrose in Water | 178 | $594 | $3 |
| Valsartan | 25 | $553 | $22 |
| Lisinopril | 123 | $538 | $4 |
| Lactulose | 24 | $529 | $22 |
| Lidocaine-Prilocaine | 12 | $498 | $42 |
| Ranitidine | 24 | $439 | $18 |
| Ondansetron Odt | 15 | $431 | $29 |
| Olmesartan Medoxomil | 11 | $417 | $38 |
| Clopidogrel | 39 | $416 | $11 |
| Prednisone | 22 | $384 | $17 |
| Oxybutynin Chloride | 11 | $378 | $34 |
| Gabapentin | 58 | $330 | $6 |
| Ropinirole | 34 | $313 | $9 |
| Spironolactone | 24 | $309 | $13 |
| Levofloxacin | 32 | $291 | $9 |
| Simvastatin | 48 | $276 | $6 |
| Glipizide | 48 | $274 | $6 |
| Pramipexole Dihydrochloride | 14 | $269 | $19 |
| Glipizide Er | 19 | $266 | $14 |
| Rosuvastatin | 12 | $238 | $20 |
| Levetiracetam | 11 | $233 | $21 |
| Irbesartan | 12 | $208 | $17 |
| Metoclopramide | 36 | $201 | $6 |
| Isosorbide Mononitrate Er | 11 | $177 | $16 |
| Benazepril | 20 | $161 | $8 |
| Famotidine | 21 | $158 | $8 |
| Insulin | 11 | $152 | $14 |
| Metformin | 16 | $146 | $9 |
| Atenolol | 18 | $144 | $8 |
| Azithromycin | 20 | $129 | $6 |
| Amiodarone | 18 | $125 | $7 |
| Temazepam | 18 | $106 | $6 |
| Zolpidem | 12 | $99 | $8 |
| Ciprofloxacin | 30 | $98 | $3 |
| Montelukast | 13 | $95 | $7 |
| Cephalexin | 20 | $72 | $4 |
| Clonazepam | 11 | $16 | $1 |
2017: 106 drugs
| Renvela | 501 | $833,007 | $1,663 |
| Sensipar | 321 | $362,173 | $1,128 |
| Uloric | 216 | $76,803 | $356 |
| Renagel | 27 | $58,320 | $2,160 |
| Prosol | 161 | $46,884 | $291 |
| Trulicity | 36 | $24,337 | $676 |
| Lantus Solostar | 53 | $23,922 | $451 |
| Sevelamer Carbonate | 16 | $19,802 | $1,238 |
| Lantus | 32 | $15,896 | $497 |
| Tradjenta | 16 | $13,127 | $820 |
| Levemir Flextouch | 24 | $12,545 | $523 |
| Auryxia | 13 | $12,256 | $943 |
| Fosrenol | 11 | $11,601 | $1,055 |
| Januvia | 21 | $9,983 | $475 |
| Novolog Flexpen | 12 | $7,939 | $662 |
| Calcium Acetate | 91 | $7,671 | $84 |
| Humalog Kwikpen U-100 | 16 | $7,205 | $450 |
| Eliquis | 16 | $6,338 | $396 |
| Calcitriol | 305 | $6,061 | $20 |
| Kombiglyze Xr | 13 | $5,776 | $444 |
| Nexium | 20 | $5,088 | $254 |
| Dexilant | 15 | $4,881 | $325 |
| Dextrose in Water | 91 | $4,117 | $45 |
| Midodrine | 67 | $3,759 | $56 |
| Atorvastatin | 143 | $3,370 | $24 |
| Labetalol | 72 | $3,247 | $45 |
| Lyrica | 15 | $3,041 | $203 |
| Clonidine | 13 | $2,757 | $212 |
| Nifedipine Er | 69 | $2,637 | $38 |
| Vascepa | 20 | $2,279 | $114 |
| Clinisol | 11 | $1,874 | $170 |
| Metolazone | 28 | $1,807 | $65 |
| Losartan | 307 | $1,688 | $5 |
| Hydralazine | 151 | $1,681 | $11 |
| Levothyroxine | 77 | $1,490 | $19 |
| Potassium Chloride | 73 | $1,396 | $19 |
| Megestrol Acetate | 43 | $1,373 | $32 |
| Bystolic | 11 | $1,344 | $122 |
| Ultra-Fine Short Pen Needle | 34 | $1,340 | $39 |
| Pravastatin | 100 | $1,319 | $13 |
| Bumetanide | 28 | $1,315 | $47 |
| Gentamicin Sulfate | 27 | $1,294 | $48 |
| Allopurinol | 111 | $1,270 | $11 |
| Carvedilol | 211 | $1,179 | $6 |
| Ultra-Fine Nano Pen Needle | 20 | $1,161 | $58 |
| Amlodipine Besylate | 272 | $1,157 | $4 |
| Furosemide | 276 | $1,110 | $4 |
| Minoxidil | 52 | $1,039 | $20 |
| Ondansetron | 35 | $1,033 | $30 |
| Lisinopril | 221 | $1,016 | $5 |
| Metoprolol | 49 | $1,000 | $20 |
| Valsartan | 37 | $959 | $26 |
| Clonidine | 122 | $953 | $8 |
| Tamsulosin | 64 | $867 | $14 |
| Lidocaine-Prilocaine | 33 | $811 | $25 |
| Omeprazole | 72 | $609 | $8 |
| Rosuvastatin | 12 | $598 | $50 |
| Pantoprazole | 63 | $528 | $8 |
| Spironolactone | 57 | $459 | $8 |
| Simvastatin | 63 | $445 | $7 |
| Isosorbide Mononitrate Er | 30 | $443 | $15 |
| Gabapentin | 91 | $423 | $5 |
| Irbesartan | 22 | $393 | $18 |
| Metoprolol | 98 | $385 | $4 |
| Prednisone | 29 | $383 | $13 |
| Glipizide | 98 | $380 | $4 |
| Alprazolam | 37 | $363 | $10 |
| Ciprofloxacin | 61 | $350 | $6 |
| Phenytoin Sodium Extended | 12 | $342 | $29 |
| Azithromycin | 48 | $335 | $7 |
| Ranitidine | 14 | $334 | $24 |
| Lactulose | 13 | $325 | $25 |
| Clopidogrel | 64 | $318 | $5 |
| Insulin | 14 | $298 | $21 |
| Glimepiride | 24 | $291 | $12 |
| Hydrocodone-Acetaminophen | 24 | $283 | $12 |
| Glipizide Er | 27 | $275 | $10 |
| Pramipexole Dihydrochloride | 20 | $269 | $13 |
| Enalapril Maleate | 11 | $269 | $24 |
| Doxepin | 14 | $265 | $19 |
| Amitriptyline | 17 | $260 | $15 |
| Ropinirole | 34 | $259 | $8 |
| Klor-Con Sprinkle | 18 | $239 | $13 |
| Duloxetine | 14 | $226 | $16 |
| Temazepam | 33 | $215 | $7 |
| Meclizine | 15 | $200 | $13 |
| Kionex | 13 | $186 | $14 |
| Levofloxacin | 24 | $183 | $8 |
| Metoclopramide | 42 | $157 | $4 |
| Ondansetron Odt | 11 | $129 | $12 |
| Lovastatin | 28 | $129 | $5 |
| Metformin | 26 | $122 | $5 |
| Zolpidem | 17 | $113 | $7 |
| Benazepril | 19 | $111 | $6 |
| Famotidine | 27 | $106 | $4 |
| Montelukast | 13 | $100 | $8 |
| Pioglitazone | 14 | $99 | $7 |
| Sertraline | 15 | $90 | $6 |
| Hydroxyzine | 13 | $85 | $7 |
| Atenolol | 21 | $77 | $4 |
| Citalopram Hbr | 17 | $56 | $3 |
| Amoxicillin | 19 | $54 | $3 |
| Lorazepam | 18 | $54 | $3 |
| Carisoprodol | 11 | $47 | $4 |
| Cephalexin | 14 | $46 | $3 |
| Tramadol | 23 | $38 | $2 |
2016: 72 drugs
| Renvela | 358 | $580,219 | $1,621 |
| Sensipar | 264 | $281,279 | $1,065 |
| Renagel | 29 | $52,475 | $1,809 |
| Uloric | 112 | $29,188 | $261 |
| Lantus Solostar | 43 | $26,224 | $610 |
| Fosrenol | 12 | $18,002 | $1,500 |
| Dexilant | 24 | $6,863 | $286 |
| Calcium Acetate | 54 | $6,332 | $117 |
| Nexium | 19 | $4,868 | $256 |
| Humalog Kwikpen U-100 | 16 | $4,174 | $261 |
| Kombiglyze Xr | 11 | $4,009 | $364 |
| Niacin Er | 21 | $3,082 | $147 |
| Midodrine | 44 | $2,230 | $51 |
| Calcitriol | 147 | $2,086 | $14 |
| Valsartan | 23 | $1,951 | $85 |
| Tamsulosin | 55 | $1,806 | $33 |
| Metolazone | 21 | $1,672 | $80 |
| Spironolactone | 147 | $1,370 | $9 |
| Labetalol | 40 | $1,268 | $32 |
| Bd Ultra-Fine Pen Needle | 27 | $1,264 | $47 |
| Levothyroxine | 73 | $1,221 | $17 |
| Potassium Chloride | 56 | $1,215 | $22 |
| Lisinopril | 170 | $961 | $6 |
| Pravastatin | 70 | $882 | $13 |
| Bumetanide | 16 | $716 | $45 |
| Duloxetine | 33 | $713 | $22 |
| Hydralazine | 76 | $685 | $9 |
| Furosemide | 185 | $673 | $4 |
| Lidocaine-Prilocaine | 29 | $661 | $23 |
| Atorvastatin | 61 | $642 | $11 |
| Amlodipine Besylate | 190 | $632 | $3 |
| Losartan | 127 | $612 | $5 |
| Megestrol Acetate | 23 | $611 | $27 |
| Nifedipine Er | 23 | $586 | $25 |
| Allopurinol | 46 | $502 | $11 |
| Ropinirole | 29 | $484 | $17 |
| Nifedical Xl | 27 | $454 | $17 |
| Omeprazole | 76 | $440 | $6 |
| Prednisone | 46 | $390 | $8 |
| Metoprolol | 26 | $368 | $14 |
| Doxepin | 17 | $343 | $20 |
| Hydrocodone-Acetaminophen | 21 | $343 | $16 |
| Minoxidil | 18 | $322 | $18 |
| Clonidine | 43 | $292 | $7 |
| Carvedilol | 62 | $291 | $5 |
| Fenofibrate | 13 | $250 | $19 |
| Gabapentin | 62 | $243 | $4 |
| Levofloxacin | 20 | $234 | $12 |
| Ciprofloxacin | 45 | $215 | $5 |
| Lactulose | 13 | $192 | $15 |
| Ondansetron | 20 | $182 | $9 |
| Pioglitazone | 22 | $172 | $8 |
| Kionex | 14 | $167 | $12 |
| Metoprolol | 41 | $158 | $4 |
| Clopidogrel | 19 | $155 | $8 |
| Glipizide | 40 | $154 | $4 |
| Lovastatin | 24 | $129 | $5 |
| Citalopram Hbr | 34 | $128 | $4 |
| Glipizide Xl | 12 | $110 | $9 |
| Azithromycin | 16 | $106 | $7 |
| Pantoprazole | 14 | $105 | $7 |
| Ranitidine | 11 | $100 | $9 |
| Warfarin | 12 | $92 | $8 |
| Cephalexin | 24 | $90 | $4 |
| Temazepam | 14 | $83 | $6 |
| Metoclopramide | 14 | $76 | $5 |
| Alprazolam | 11 | $65 | $6 |
| Zolpidem | 14 | $65 | $5 |
| Simvastatin | 19 | $64 | $3 |
| Benazepril | 20 | $63 | $3 |
| Hydroxyzine | 12 | $45 | $4 |
| Amoxicillin | 11 | $26 | $2 |
2015: 92 drugs
| Renvela | 297 | $387,472 | $1,305 |
| Sensipar | 322 | $299,106 | $929 |
| Uloric | 274 | $70,566 | $258 |
| Velphoro | 17 | $31,089 | $1,829 |
| Fosrenol | 13 | $20,736 | $1,595 |
| Renagel | 11 | $20,057 | $1,823 |
| Prosol | 40 | $14,433 | $361 |
| Calcium Acetate | 91 | $14,204 | $156 |
| Lantus Solostar | 20 | $11,270 | $564 |
| Novolog Flexpen | 13 | $11,204 | $862 |
| Levemir | 14 | $10,797 | $771 |
| Crestor | 33 | $9,816 | $297 |
| Nexium | 30 | $9,272 | $309 |
| Lyrica | 36 | $8,100 | $225 |
| Bystolic | 36 | $5,497 | $153 |
| Calcitriol | 245 | $4,542 | $19 |
| Levemir Flextouch | 11 | $4,236 | $385 |
| Effient | 12 | $3,785 | $315 |
| Paricalcitol | 11 | $3,751 | $341 |
| Hydrocodone-Acetaminophen | 117 | $3,206 | $27 |
| Donepezil | 11 | $3,179 | $289 |
| Symbicort | 11 | $2,973 | $270 |
| Midodrine | 39 | $2,904 | $74 |
| Pravastatin | 112 | $2,322 | $21 |
| Tamsulosin | 73 | $1,855 | $25 |
| Levothyroxine | 113 | $1,681 | $15 |
| Valsartan | 13 | $1,604 | $123 |
| Atorvastatin | 142 | $1,537 | $11 |
| Dextrose in Water | 34 | $1,445 | $43 |
| Nifedipine Er | 25 | $1,358 | $54 |
| Lidocaine-Prilocaine | 33 | $1,088 | $33 |
| Allopurinol | 107 | $1,059 | $10 |
| Metoprolol | 35 | $1,057 | $30 |
| Spironolactone | 64 | $1,002 | $16 |
| Lisinopril | 169 | $943 | $6 |
| Clonidine | 11 | $925 | $84 |
| Metolazone | 20 | $909 | $45 |
| Ropinirole | 60 | $861 | $14 |
| Furosemide | 166 | $845 | $5 |
| Clonidine | 75 | $760 | $10 |
| Hydralazine | 63 | $753 | $12 |
| Fenofibrate | 24 | $747 | $31 |
| Proair Hfa | 14 | $735 | $53 |
| Bd Ultra-Fine Pen Needle | 19 | $674 | $35 |
| Bumetanide | 14 | $659 | $47 |
| Losartan | 80 | $648 | $8 |
| Simvastatin | 122 | $613 | $5 |
| Doxazosin Mesylate | 20 | $591 | $30 |
| Amlodipine Besylate | 126 | $589 | $5 |
| Minoxidil | 32 | $541 | $17 |
| Enalapril Maleate | 19 | $541 | $28 |
| Omeprazole | 76 | $541 | $7 |
| Novofine | 14 | $504 | $36 |
| Warfarin | 65 | $480 | $7 |
| Carvedilol | 63 | $474 | $8 |
| Ondansetron | 13 | $454 | $35 |
| Clopidogrel | 33 | $448 | $14 |
| Gabapentin | 70 | $389 | $6 |
| Pantoprazole | 51 | $370 | $7 |
| Lactulose | 17 | $367 | $22 |
| Metoprolol | 101 | $325 | $3 |
| Kionex | 12 | $322 | $27 |
| Lovastatin | 20 | $305 | $15 |
| Glipizide | 60 | $289 | $5 |
| Bupropion Hcl Sr | 12 | $250 | $21 |
| Isosorbide Mononitrate Er | 14 | $217 | $16 |
| Amitriptyline | 13 | $214 | $16 |
| Levofloxacin | 40 | $205 | $5 |
| Torsemide | 11 | $203 | $18 |
| Zolpidem | 20 | $199 | $10 |
| Escitalopram | 29 | $181 | $6 |
| Cyclobenzaprine | 31 | $172 | $6 |
| Glipizide Er | 12 | $141 | $12 |
| Citalopram Hbr | 34 | $137 | $4 |
| Lorazepam | 11 | $128 | $12 |
| Nystatin | 11 | $125 | $11 |
| Temazepam | 19 | $123 | $6 |
| Azithromycin | 19 | $117 | $6 |
| Glimepiride | 19 | $106 | $6 |
| Alprazolam | 22 | $92 | $4 |
| Cilostazol | 11 | $92 | $8 |
| Quetiapine | 11 | $89 | $8 |
| Buspirone | 11 | $87 | $8 |
| Cephalexin | 17 | $84 | $5 |
| Fluoxetine | 14 | $81 | $6 |
| Amoxicillin | 27 | $72 | $3 |
| Paroxetine | 11 | $71 | $6 |
| Sertraline | 11 | $68 | $6 |
| Metoclopramide | 14 | $67 | $5 |
| Ciprofloxacin | 12 | $60 | $5 |
| Famotidine | 16 | $44 | $3 |
| Sotalol | 12 | $30 | $3 |
2014: 72 drugs
| Renvela | 185 | $219,530 | $1,187 |
| Sensipar | 182 | $159,320 | $875 |
| Prosol | 87 | $22,443 | $258 |
| Uloric | 87 | $21,536 | $248 |
| Calcium Acetate | 106 | $15,791 | $149 |
| Lyrica | 60 | $11,520 | $192 |
| Levemir | 17 | $9,107 | $536 |
| Nexium | 25 | $8,827 | $353 |
| Januvia | 15 | $5,895 | $393 |
| Effient | 17 | $4,560 | $268 |
| Hydrocodone-Acetaminophen | 184 | $3,825 | $21 |
| Calcitriol | 148 | $3,379 | $23 |
| Crestor | 15 | $3,226 | $215 |
| Bystolic | 21 | $2,891 | $138 |
| Lantus Solostar | 11 | $2,843 | $258 |
| Pravastatin | 74 | $1,916 | $26 |
| Dextrose in Water | 39 | $1,658 | $43 |
| Atorvastatin | 88 | $1,330 | $15 |
| Levothyroxine | 76 | $1,179 | $16 |
| Oxycodone-Acetaminophen | 16 | $1,152 | $72 |
| Midodrine | 19 | $1,136 | $60 |
| Hydralazine | 62 | $1,074 | $17 |
| Temazepam | 39 | $925 | $24 |
| Nifedipine Er | 14 | $877 | $63 |
| Clonidine | 84 | $843 | $10 |
| Bd Ultra-Fine Pen Needle | 21 | $709 | $34 |
| Amlodipine Besylate | 128 | $691 | $5 |
| Metolazone | 16 | $686 | $43 |
| Lisinopril | 115 | $628 | $5 |
| Ropinirole | 46 | $614 | $13 |
| Metoprolol | 15 | $606 | $40 |
| Furosemide | 104 | $539 | $5 |
| Simvastatin | 83 | $522 | $6 |
| Omeprazole | 48 | $501 | $10 |
| Carvedilol | 53 | $462 | $9 |
| Zolpidem | 46 | $460 | $10 |
| Warfarin | 68 | $454 | $7 |
| Megestrol Acetate | 17 | $447 | $26 |
| Doxazosin Mesylate | 20 | $446 | $22 |
| Tamsulosin | 31 | $435 | $14 |
| Fenofibrate | 11 | $422 | $38 |
| Lidocaine-Prilocaine | 16 | $404 | $25 |
| Escitalopram | 39 | $397 | $10 |
| Gabapentin | 51 | $392 | $8 |
| Allopurinol | 64 | $382 | $6 |
| Losartan | 43 | $371 | $9 |
| Cyclobenzaprine | 31 | $340 | $11 |
| Metoprolol | 76 | $317 | $4 |
| Ondansetron | 15 | $296 | $20 |
| Clopidogrel | 15 | $280 | $19 |
| Minoxidil | 16 | $275 | $17 |
| Glipizide | 43 | $272 | $6 |
| Prednisone | 24 | $252 | $11 |
| Pantoprazole | 27 | $238 | $9 |
| Alprazolam | 53 | $227 | $4 |
| Levofloxacin | 38 | $217 | $6 |
| Sodium Polystyrene Sulfonate | 14 | $209 | $15 |
| Azithromycin | 28 | $188 | $7 |
| Glipizide Er | 13 | $183 | $14 |
| Isosorbide Mononitrate Er | 13 | $166 | $13 |
| Spironolactone | 18 | $156 | $9 |
| Citalopram Hbr | 30 | $146 | $5 |
| Tramadol | 17 | $142 | $8 |
| Quetiapine | 12 | $125 | $10 |
| Cephalexin | 29 | $109 | $4 |
| Clonazepam | 12 | $104 | $9 |
| Amoxicillin | 36 | $102 | $3 |
| Glimepiride | 16 | $91 | $6 |
| Ciprofloxacin | 13 | $82 | $6 |
| Famotidine | 14 | $65 | $5 |
| Lorazepam | 14 | $58 | $4 |
| Metoclopramide | 13 | $56 | $4 |
2013: 5 drugs
| Renvela | 13 | $14,727 | $1,133 |
| Calcium Acetate | 17 | $1,691 | $99 |
| Hydrocodone-Acetaminophen | 30 | $552 | $18 |
| Calcitriol | 19 | $488 | $26 |
| Amlodipine Besylate | 12 | $105 | $9 |
Money from drug and device companies
$334 in 2025
| 2025 | 7 | 11 | None | $334 |
| 2024 | 5 | 6 | None | $254 |
| 2023 | 3 | 6 | None | $106 |
| 2022 | 4 | 4 | None | $137 |
| 2021 | 8 | 12 | None | $221 |
| 2020 | 8 | 18 | None | $289 |
| 2019 | 15 | 48 | None | $975 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Lokelma | $140 | 2 payments
|
| Idorsia Pharmaceuticals US | Tryvio | $52 | 1 payment
|
| Akebia Therapeutics | Vafseo | $46 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $39 | 1 payment
|
| Amgen | Krystexxa | $23 | 1 payment
|
| Novartis Pharmaceuticals | None | $19 | 1 payment
|
See all 9 published payments
| Mallinckrodt Hospital Products | Meals · 2025-11-05 | Acthar | $39 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-27 | None | $118 |
| Idorsia Pharmaceuticals US | Education · 2025-09-19 | Tryvio | $52 |
| Akebia Therapeutics | Meals · 2025-06-26 | Vafseo | $26 |
| Akebia Therapeutics | Meals · 2025-04-17 | Vafseo | $20 |
| Fresenius USA Marketing | Meals · 2025-04-11 | Velphoro | $15 |
| Amgen | Meals · 2025-03-24 | Krystexxa | $23 |
| Novartis Pharmaceuticals | Meals · 2025-02-24 | None | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-04 | Lokelma | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $254
| Mallinckrodt Hospital Products | Acthar | $133 | 1 payment
|
| GlaxoSmithKline | Jesduvroq | $44 | 2 payments
|
| Amgen | Krystexxa | $27 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $27 | 1 payment
|
| Kyowa Kirin | Crysvita | $22 | 1 payment
|
2023: $106
| GlaxoSmithKline | Benlysta | $70 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $19 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $17 | 1 payment
|
2022: $137
| Mallinckrodt Hospital Products | Acthar | $95 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $16 | 1 payment
|
| Exeltis USA | Purified Cortrophin Gel | $14 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $12 | 1 payment
|
2021: $221
| Vifor Pharma | None | $45 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $44 | 3 payments
|
| Horizon Therapeutics plc | Krystexxa | $32 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $31 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $23 | 1 payment
|
| GlaxoSmithKline | Benlysta | $19 | 1 payment
|
| Amgen | Parsabiv | $15 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $12 | 1 payment
|
2020: $289
| Daiichi Sankyo | Injectafer | $70 | 4 payments
|
| Fresenius USA Marketing | Velphoro | $56 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $47 | 3 payments
|
| Otsuka America Pharmaceutical | Jynarque | $34 | 2 payments
|
| Amgen | Parsabiv | $29 | 2 payments
|
| Argon Medical Devices | Option | $21 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $16 | 1 payment
|
| Boston Scientific | General - Pain Management | $16 | 1 payment
|
2019: $975
| Relypsa | Veltassa | $289 | 6 payments
|
| Fresenius USA Marketing | Velphoro | $219 | 15 payments
|
| Otsuka America Pharmaceutical | Jynarque | $123 | 7 payments
|
| Amgen | Parsabiv | $72 | 5 payments
|
| Akebia Therapeutics | Auryxia | $57 | 4 payments
|
| Baxter Healthcare | Renal - Pd | $47 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $29 | 2 payments
|
| Alexion Pharmaceuticals | Soliris | $26 | 1 payment
|
| Shire North American Group | Natpara (Parathyroid Hormone) | $23 | 1 payment
|
| Genentech USA | Rituxan | $19 | 1 payment
|
| Mallinckrodt Enterprises | Acthar | $18 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $15 | 1 payment
|
| Daiichi Sankyo | Injectafer | $15 | 1 payment
|
| Genzyme | Fabry-Disease | $12 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $11 | 1 payment
|
Professional record
- NPI
- 1881997872
- Licence
- CA A123534California A123534: Current · expires 2028-07-31
- Group
- The Nephrology Group Inc · Altura Centers for Health
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 568 E. Herndon Ave., Suite 201, Fresno, CA, 93720
- NPI first listed
- 2010-12-13
- NPI last updated
- 2023-03-08
- NPI record certified
- 2023-03-08
This is when the NPI record was last certified, not a medical board exam.